Aytu Biopharma Inc (AYTU)

Überblick Nachrichten Preisverlauf Financials Warum fällt AYTU? Forum Prognose Aktiensplit

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.19% 15.16	13.89	15.13	18.45	16.22
Cost Of Revenue	17.84% 5.541	4.702	4.881	5.646	5.435
Gross Profit	4.77% 9.624	9.186	10.25	12.81	10.79
Operating Expenses	8.46% 11.59	10.69	17.88	10.38	12.48
Benefits Costs and Expenses	115.96% 25.75	11.92	34.58	14.63	15.84
Costs And Expenses	115.96% 25.75	11.92	34.58	14.63	15.84
Operating Income/Loss	30.98% -1.97	-1.504	-7.623	2.421	-1.695
Income/Loss From Continuing Operations Before Tax	638.63% -10.58	1.965	-19.44	3.818	0.382
Income Tax Expense/Benefit	-	-	0.437	-0.122	-0.283
Income/Loss From Continuing Operations After Tax	638.63% -10.58	1.965	-19.88	3.94	0.665
Income/Loss From Discontinued Operations, Net Of Tax	-	-	0.062	0.054	0.123
Net Income/Loss	638.63% -10.58	1.965	-19.82	3.994	0.788
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6.31% 10.04	9.4411	0.1682	6.1346	6.1321
Diluted Average Shares	48.47% 10.04	19.48	-	8.2045	8.4851
Basic Earnings Per Share	600.00% -1.05	0.21	-3.18	0.65	0.13
Diluted Earnings Per Share	1,212% -1.05	-0.08	-	0.21	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%